2023
DOI: 10.1016/j.ejmech.2023.115415
|View full text |Cite
|
Sign up to set email alerts
|

Oxazole-4-carboxamide/butylated hydroxytoluene hybrids with GSK-3β inhibitory and neuroprotective activities against Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 56 publications
0
6
0
Order By: Relevance
“…Eight compounds, 6QH, donepezil (E20), BHT, EGCG, CNS-11, BHT-6QH, BHT-E20, and BHT-CNS-11, were examined, and their structure–activity relationships are summarized in Table 1 . 6QH [ 43 ] and E20 [ 44 ] are known inhibitors of the 3β isoform of glycogen synthase kinase (GSK-3β) and acetylcholinesterase (AChE) and are associated with the hyperphosphorylation of tau and the degradation of acetylcholine in neurons, respectively. Inhibitions of GSK-3β and AChE can disrupt the tau aggregation pathway [ 45 , 46 , 47 ] and improve acetylcholine signaling [ 44 ].…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Eight compounds, 6QH, donepezil (E20), BHT, EGCG, CNS-11, BHT-6QH, BHT-E20, and BHT-CNS-11, were examined, and their structure–activity relationships are summarized in Table 1 . 6QH [ 43 ] and E20 [ 44 ] are known inhibitors of the 3β isoform of glycogen synthase kinase (GSK-3β) and acetylcholinesterase (AChE) and are associated with the hyperphosphorylation of tau and the degradation of acetylcholine in neurons, respectively. Inhibitions of GSK-3β and AChE can disrupt the tau aggregation pathway [ 45 , 46 , 47 ] and improve acetylcholine signaling [ 44 ].…”
Section: Resultsmentioning
confidence: 99%
“…Note that 6QH, E20, and CNS-11 do not have antioxidant activity. To add antioxidation activity to these molecules, a BHT moiety was covalently attached to the pharmacophore regions of these molecules to create new BHT-containing hybrids, BHT–6QH [ 43 ], BHT–E20 [ 49 ], and BHT–CNS-11. The first two hybrids have demonstrated dual enzyme inhibition and antioxidant activities, while the last hybrid has potential antioxidant and tau fibril disaggregation activities that await experimental validation.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations